Dr. Chapa’s OBGYN Clinical Pearls
Oriahnn for Fibroids HMB (New Med Approval)
7 min•20 juni 2020
Om avsnittet
On May 29, 2020, the U.S. FDA approved an novel oral drug, Oriahnn, for HMB use to fibroids. This medication (elagolix, estradiol, and norethindrone acetate) is the first oral medication designed specifically for Fibroid HMB. In this session, we will review this new medication. (No financial disclosures to report).
Dr. Chapa’s OBGYN Clinical Pearls med Dr. Chapa’s Clinical Pearls finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.